Acta Pharmacologica Sinica Фармакология

IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib

Yi Ning, Yu Zhou, Qi Zhang, Zhi-wei Chen, Yu-qing Huang, Qi Zhang, Yun Chen, Wen-hao Shi, Qiu-pei Liu, Ya-ping Xue, Tao Zhang, Jian Ding, Wen-hu Duan, Hua Xie
Springer Nature · 2026-11-16 · DOI 10.1038/s41401-026-01953-z
⬢ Цитируемость: 0 Crossref

Аннотация

Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib

Читать у издателя →